#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

Search results: (10000)



Journal articles Management of convulsive status epilepticus in children

Author of the article: Š. Aulická, P. Aulický, K. Česká, K. Španělová, H. Ošlejšková Source: Anesteziologie a intenzivní medicína | 3/2018 14. 7. 2018

News First Experiences with the Combination of Levodopa/Entacapone/Carbidopa in Intestinal Gel from the Perspective of Patients with Parkinson's Disease

The work presented at the 8th Congress of the European Academy of Neurology (EAN) in Vienna in June 2022 summarizes the first experiences with the use of intestinal gel combining the active ingredients levodopa/entacapone/carbidopa in patients with Parkinson’s disease (PD) in clinical practice in Austria.
Source: Parkinson's Disease 22. 11. 2022

Journal articles Ovarian epithelial malignant tumors in adolescence

Author of the article: Luboš Minář, Z. Ivanová, E. Jandáková Source: Česká gynekologie | 2/2014 21. 4. 2014

News Impact of Combined Oral Contraceptives on Body Weight

A relatively recent study investigated changes in the average body weight of women who used combined oral contraceptives with 30 μg ethinylestradiol (EE) and 3 mg drospirenone (DRSP) or 30 μg EE and 2 mg chlormadinone acetate (CMA) for 6 months, comparing the results between the two groups.
Source: Oral Contraception 10. 4. 2022

News Interactive Case Study: Use of Cannabis Extract for Local Treatment of Neuropathic Pain

We have been using cannabis for pain treatment for several years. We also have good experiences with it in difficult-to-control symptoms of neuropathic pain, as illustrated in the following case study. Until recently, our patients only used cannabis orally or via vaporization. With the availability of cannabis extracts, a new option has emerged –⁠ local therapy.
Source: Medical Cannabis 19. 6. 2024

Journal articles Breast cancer in elderly patients over 70 years of age

Author of the article: J. Gatěk, V. Petrů, P. Kosáč, J. Šťastný, M. Ratajský, J. Duben, B. Dudešek, M. Zábojníková, D. Vrána Source: Rozhledy v chirurgii | 1/2018 7. 1. 2018

Journal articles Has everything really been discovered about SGLT2 inhibitors?

Author of the article: Daša Skripová Source: Diabetes a obezita | 38/2019 8. 2. 2020

News How to Choose the Ideal Venotonic or Vasoprotective –⁠ Which Properties Are Key?

Medicines and dietary supplements containing flavonoids, often hesperidin or diosmin, are available on the market. What should you consider when choosing these products?
Source: Venous Insufficiency 11. 2. 2020

News Dravet Syndrome –⁠ Get to Know It

Dravet syndrome is a severe myoclonic epilepsy occurring in early childhood. It is classified as a rare progressive epileptic encephalopathy, characterized by generalized or lateralized clonic seizures often prolonged and linked to febrile infections. Other forms of seizures later appear, leading to deterioration in psychomotor development and the onset of mental retardation. Early diagnosis and treatment are desirable.
Source: Rare Diseases in Neurology 2. 5. 2023

News Low Molecular Weight Heparin in an ECMO Patient −⁠ Case Study

Extracorporeal membrane oxygenation (ECMO) has an irreplaceable role in intensive care medicine. In the context of preventing complications caused by blood clot formation, unfractionated heparin is most commonly used in patients on extracorporeal circulation. However, its administration can lead to complex coagulopathies, which may result in increased bleeding or, perhaps surprisingly, a higher frequency of blood clot formation. A unique case study recently presented by authors from Motol University Hospital in Prague demonstrates the safety and effectiveness of using low molecular weight heparin (LMWH) enoxaparin in this indication for a patient connected to ECMO for a very long duration (3 months), with several days even on two devices simultaneously.
Source: Thromboprophylaxis 28. 11. 2023

Journal articles Type 2 diabetes mellitus and bone quality

Author of the article: MUDr. Raška Ivan, Ph.D. Source: Clinical Osteology | 3/2018 14. 5. 2019

Journal articles Vascular age

Author of the article: Ondřej Petrák, Richard Češka Source: Vnitřní lékařství | 12/2019 19. 1. 2020

News Memantine Eases Daily Life for Patients and Caregivers

What is the efficacy and safety of memantine in patients with Alzheimer's disease in routine practice in the Czech Republic? And to what extent can it ease the burden on caregivers of these patients?
Source: Cognitive in the treatment of Alzheimer's disease 12. 10. 2020

News Allergic Rhinitis in the General Practitioner’s Office: How to Proceed in Primary Care?

Up to 60% of the population has a genetic predisposition to allergic disease. Diagnosis and therapy of allergic conditions are therefore very common topics in primary care. How should we proceed correctly in the diagnostic process when suspecting allergic rhinitis? When to refer to a specialist and what are the treatment options?
Source: Life Without Allergic Rhinitis 7. 6. 2022

News How Important is the Time Factor in the Treatment of Heart Failure?

Current guidelines emphasize the importance of early diagnosis and immediate treatment for patients with heart failure (HF). These patients are most vulnerable immediately after the decompensation of chronic HF, and intensive treatment can therefore reduce the risk of further hospitalization and mortality. The prognosis for these patients is unfavorable, and any delay in initiating therapy further worsens it. The treatment of chronic HF is often postponed if the symptoms are stable, and the risk of adverse outcomes and sudden death is underestimated. The time factor thus plays a significant role in all stages of HF.
Source: Heart Failure 13. 11. 2023

News How can inosine pranobex help with viral infections?

Inosine pranobex has long been used for its immunomodulatory and antiviral effects in the prophylaxis and therapy of various viral infections. Below we summarize its mechanism of action, indications, usage, and side effects.
Source: Viral infections 16. 2. 2023

News Indication of Bilastine in Specific Patient Groups −⁠ Practical Tips for Clinical Practice

Bilastine is a non-sedating H1-antihistamine, which is very well tolerated by patients. It can be indicated in the therapy of allergic diseases in both pediatric and adult populations. What are the possibilities of its use in specific patient groups?
Source: Allergic Reactions 24. 5. 2022

News Beta-blockers in the treatment of chronic heart failure: How did the analysis of the effects of 4 drugs in 26 studies turn out?

As a cornerstone of therapy for chronic heart failure with reduced ejection fraction (HFrEF), it is recommended to start treatment with a very low dose of beta-blockers (BB) and titrate it to the maximum tolerated dose. However, it remains unclear whether one BB is superior to others. For this reason, a comprehensive pooled analysis of the efficacy and safety of bisoprolol, carvedilol, nebivolol, and metoprolol in 26 studies, including 14 randomized controlled and 12 observational, was recently published.
Source: Cardiovascular Continuum 28. 3. 2023

News Long-term Keto Diet May Damage Our Organs

Source: 5. 12. 2024

News How to Save a Leg from Amputation?

Feared complications in diabetics include defects in typical locations on the lower limbs. Their presence and frequent recurrences increase the risk of possible amputation of varying degrees, mainly depending on the involvement of deep structures, i.e., tendons, joint capsules, joints, and bones. How can this scenario be avoided? One answer might be HydroTherapy.
Source: Wound Healing 10. 8. 2022

News Nasal Smear as a Modern and Gentle Diagnostic Method for Allergic Rhinitis

Up to 130 million Europeans suffer from allergic rhinitis. Until now, standard diagnostic methods have been skin prick tests and laboratory blood tests. Both methods, however, present significant discomfort for many patients, and skin prick tests can also yield false-positive results. That's why researchers are focusing on new diagnostic possibilities for allergic rhinitis.
Source: Allergic Reactions 14. 10. 2021

News Comparison of 5 Beta-Blockers in Heart Failure with Reduced Ejection Fraction

An analysis of 26 studies with beta-blockers in the treatment of heart failure with reduced ejection fraction compared 5 drugs (bisoprolol, metoprolol-succinate, metoprolol-tartrate, carvedilol, and nebivolol). The results showed a more favorable prognosis with bisoprolol compared to carvedilol, a similar effect on prognosis for carvedilol, metoprolol-succinate, and nebivolol, and the least favorable prognosis with metoprolol-tartrate.
Source: Cardiovascular Continuum 24. 4. 2024

News Evaluation of Joint Condition in Daily Practice in the Era of New Hemophilia Treatment

With the development of new treatment options for hemophilia, there has also been progress in methods for monitoring hemophilic arthropathy and identifying it in its early stages. In addition to classical X-rays, clinical scoring systems, and the gold standard of magnetic resonance imaging (MRI), the so-called POCUS –⁠ point-of-care ultrasound –⁠ has emerged as a quick and reliable method for assessing joint health. Potential biomarkers for osteochondral damage and synovial proliferation specific to hemophilia or for detecting joint bleeding are also being investigated, though their routine use is not anticipated in the near future.
Source: Hemophilia 10. 6. 2024

News Does olaparib improve overall survival in patients with recurrent ovarian cancer and BRCA mutation?

Olaparib, a poly(ADP-ribose) polymerase (PARP) enzyme inhibitor, in tablet form is indicated, among other things, for the maintenance treatment of adult patients with platinum-sensitive recurrent high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer who respond (complete or partial response) to platinum-based chemotherapy. Its efficacy in this indication in terms of prolonging progression-free survival and overall survival was addressed by the phase III study presented below.
Source: Ovarian and Breast Cancer 13. 2. 2021

News Anticoagulants and Antiplatelets in the Treatment of Acute Coronary Syndromes

Anticoagulants and antiplatelets are a key part of the therapeutic strategies used in the treatment of acute coronary syndromes (ACS). They reduce the risk of acute and late complications, morbidity, and mortality in patients. On the other hand, their main disadvantage is the potential occurrence of bleeding complications. Therefore, the goal of physicians is to use these medications appropriately, maximizing benefits for patients while minimizing the risk of bleeding.
Source: Thromboprophylaxis 13. 6. 2022

1 49 50 51 52 53 400
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#